3 Things to Watch for in Clinical Trials This Year On June 22, 2016, Jill O’Donnell-Tormey, PhD, CEO and director of Scientific Affairs at the Cancer Research Institute, discussed the number and variety of immunotherapy clinical trials and what patients should look for. Cancer Research Institute's webinar series, "Cancer Immunotherapy and You," are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This series is presented by Genentech and LabAnswer and its employees, with generous support from Abbvie, Celldex Therapeutics, NewLink Genetics, and Regeneron. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars. Read more: Post navigation Killing Cancer: Immunotherapy for Leukemia and Lymphoma Read Story XVth NIBIT Meeting: Cancer Bio-Immunotherapy in Siena Read Story